Ulrika Regnéll

Senior scientist at Sobi - Waltham, MA, US

Ulrika Regnéll's Colleagues at Sobi
Michael Greksa

Finance, Head of Mergers and Acquisitions

Contact Michael Greksa

Helen Daly

Global Distribution Coordinator

Contact Helen Daly

Helene Caldeman

Global Brand Director Immunology

Contact Helene Caldeman

Ingela Gustafsson

Global Regulatory Affairs Manager

Contact Ingela Gustafsson

View All Ulrika Regnéll's Colleagues
Ulrika Regnéll's Contact Details
HQ
781-786-7370
Location
Greater Uppsala Area
Company
Sobi
Ulrika Regnéll's Company Details
Sobi logo, Sobi contact details

Sobi

Waltham, MA, US • 1000 - 4999 Employees
Major Drugs

Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. We are providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, we employ approximately 1,500 people across Europe, North America, Middle East and Asia. In 2020, our revenue amounted to SEK 15.3 billion. The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at sobi.com. Read our social media policy at https://www.sobi.com/en/social-media-policyYou can find out more about Sobi at https://www.youtube.com/c/sobipharma

orphan drugs hereditary metabolic disorders hematological diseases therapeutic oncology autoimmune diseases haemophilia
Details about Sobi
Frequently Asked Questions about Ulrika Regnéll
Ulrika Regnéll currently works for Sobi.
Ulrika Regnéll's role at Sobi is Senior scientist.
Ulrika Regnéll's email address is ***@sobi.com. To view Ulrika Regnéll's full email address, please signup to ConnectPlex.
Ulrika Regnéll works in the Major Drugs industry.
Ulrika Regnéll's phone number is 781-786-7370
See more information about Ulrika Regnéll